CING
Price
$4.10
Change
+$0.03 (+0.74%)
Updated
Dec 18, 04:59 PM (EDT)
KZIA
Price
$2.85
Change
-$0.55 (-16.18%)
Updated
Dec 18, 04:59 PM (EDT)
Ad is loading...

CING vs KZIA

Header iconCING vs KZIA Comparison
Open Charts CING vs KZIABanner chart's image
Cingulate
Price$4.10
Change+$0.03 (+0.74%)
Volume$129
CapitalizationN/A
Kazia Therapeutics
Price$2.85
Change-$0.55 (-16.18%)
Volume$926
CapitalizationN/A
CING vs KZIA Comparison Chart
Loading...
CING
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KZIA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CING vs. KZIA commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CING is a StrongBuy and KZIA is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (CING: $4.07 vs. KZIA: $3.40)
Brand notoriety: CING and KZIA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CING: 49% vs. KZIA: 94%
Market capitalization -- CING: $13.07M vs. KZIA: $14.81M
CING [@Biotechnology] is valued at $13.07M. KZIA’s [@Biotechnology] market capitalization is $14.81M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.68B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CING’s FA Score shows that 1 FA rating(s) are green whileKZIA’s FA Score has 0 green FA rating(s).

  • CING’s FA Score: 1 green, 4 red.
  • KZIA’s FA Score: 0 green, 5 red.
According to our system of comparison, CING is a better buy in the long-term than KZIA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CING’s TA Score shows that 4 TA indicator(s) are bullish while KZIA’s TA Score has 3 bullish TA indicator(s).

  • CING’s TA Score: 4 bullish, 4 bearish.
  • KZIA’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, CING is a better buy in the short-term than KZIA.

Price Growth

CING (@Biotechnology) experienced а -6.00% price change this week, while KZIA (@Biotechnology) price change was -5.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.91%, and the average quarterly price growth was -1.42%.

Reported Earning Dates

CING is expected to report earnings on Mar 08, 2024.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KZIA($14.8M) has a higher market cap than CING($13.1M). KZIA YTD gains are higher at: -22.639 vs. CING (-95.566).
CINGKZIACING / KZIA
Capitalization13.1M14.8M89%
EBITDAN/AN/A-
Gain YTD-95.566-22.639422%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total Debt423KN/A-
FUNDAMENTALS RATINGS
KZIA: Fundamental Ratings
KZIA
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CINGKZIA
RSI
ODDS (%)
Bullish Trend 7 days ago
84%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 10 days ago
82%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Ad is loading...
CING
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KZIA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

CING and

Correlation & Price change

A.I.dvisor tells us that CING and BTAX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CING and BTAX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CING
1D Price
Change %
CING100%
+0.99%
BTAX - CING
31%
Poorly correlated
N/A
BEIGF - CING
28%
Poorly correlated
N/A
GOVX - CING
28%
Poorly correlated
-0.87%
BIXT - CING
26%
Poorly correlated
N/A
CYTK - CING
25%
Poorly correlated
-2.53%
More

KZIA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KZIA has been closely correlated with HOOK. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if KZIA jumps, then HOOK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KZIA
1D Price
Change %
KZIA100%
+2.10%
HOOK - KZIA
73%
Closely correlated
-1.84%
FRES - KZIA
61%
Loosely correlated
-10.54%
CING - KZIA
27%
Poorly correlated
+0.99%
SRPT - KZIA
26%
Poorly correlated
-0.81%
ENLV - KZIA
24%
Poorly correlated
+1.72%
More